---
$id: https://graph.org.ai/products/commodity/51151638
$type: Product
source: UNSPSC
code: "51151638"
title: "Emepronium"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Emepronium

**UNSPSC Code**: 51151638
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscarinic antagonist and parasympatholytic with the molecular formula C20H28N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 04QQ8SWA4U, chemically known as benzenepropanaminium, n-ethyl-n,n,alpha-trimethyl-gamma-phenyl- but generally known as emepronium, which bears US NIH Compound Identifier 34055. European Medicines Agency schedules Emepronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01875MIG. World Health Organization schedules emepronium in its Anatomical Therapeutic Chemical (ATC) Classification. EMEPRONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, EMEPRONIUM remains the US FDA Preferred Term for this commodity. SMILES: [N](C(CC(C1CCCCC1)C1CCCCC1)C)(CC)(C)C.

